International prognostic scoring system and TP53 mutations are independent prognostic indicators for patients with myelodysplastic syndrome
نویسندگان
چکیده
منابع مشابه
Application of the International Prognostic Scoring System for myelodysplastic syndromes.
BACKGROUND In March 1997 an international workshop introduced a new International Prognostic Scoring System (IPSS) for MDS. The goal of the present study was to apply the IPSS to a large group of MDS patients from one centre and to compare it to the FAB-classification. PATIENTS One hundred eighty-four MDS patients were included on the basis of similar criteria as used by the workshop but some...
متن کاملMYELOID NEOPLASIA Revised International Prognostic Scoring System for Myelodysplastic Syndromes
Peter L. Greenberg,1 Heinz Tuechler,2 Julie Schanz,3 Guillermo Sanz,4 Guillermo Garcia-Manero,5 Francesc Solé,6 John M. Bennett,7 David Bowen,8 Pierre Fenaux,9 Francois Dreyfus,10 Hagop Kantarjian,5 Andrea Kuendgen,11 Alessandro Levis,12 Luca Malcovati,13 Mario Cazzola,13 Jaroslav Cermak,14 Christa Fonatsch,15 Michelle M. Le Beau,16 Marilyn L. Slovak,17 Otto Krieger,18 Michael Luebbert,19 Jaros...
متن کامل[Revised international prognostic scoring system (IPSS-R) for myelodysplastic syndromes].
Peter L. Greenberg, Heinz Tuechler, Julie Schanz, Guillermo Sanz, Guillermo GarciaManero, Francesc Solé, John M. Bennett, David Bowen, Pierre Fenaux, Francois Dreyfus, Hagop Kantarjian, Andrea Kuendgen, Alessandro Levis, Luca Malcovati, Mario Cazzola, Jaroslav Cermak, Christa Fonatsch, Michelle M. Le Beau, Marilyn L. Slovak, Otto Krieger, Michael Luebbert, Jaroslaw Maciejewski, Silvia M.M. Maga...
متن کاملThe myelodysplastic syndrome-comorbidity index provides additional prognostic information on patients stratified according to the revised international prognostic scoring system.
The myelodysplastic syndromes are a heterogeneous group of disorders of the hematopoietic stem cell and stem cell niche. The revised version of the International Prognostic Scoring System (IPSS-R), which is based on disease-related factors, was recently published. In 2010, the MDS-specific Comorbidity Index (MDS-CI) was developed by the Italian MDS study group and was validated using data of th...
متن کاملComparison of Myelodysplastic Syndrome Prognostic Scoring Systems
OBJECTIVE Myelodysplastic syndrome (MDS) is a clonal hematopoietic stem cell disease. Patients are at risk of developing cytopenias or progression to acute myeloid leukemia. Different classifications and prognostic scoring systems have been developed. The aim of this study was to compare the different prognostic scoring systems. MATERIALS AND METHODS One hundred and one patients who were diag...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: British Journal of Haematology
سال: 2001
ISSN: 0007-1048
DOI: 10.1046/j.1365-2141.2001.03073.x